Cargando…

Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation

PURPOSE: To present the 13.5-year-survival of an autologous retinal pigment epithelium (RPE) and choroid graft transplantation with good visual acuity results. OBSERVATIONS: A 72-year old patient presented with a 5-weeks-old visual acuity deterioration to excentric finger counting at half a meter. F...

Descripción completa

Detalles Bibliográficos
Autores principales: van Zeeburg, Elsbeth J.T., Maaijwee, Kristel J.M., van Meurs, Jan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956743/
https://www.ncbi.nlm.nih.gov/pubmed/29780916
http://dx.doi.org/10.1016/j.ajoc.2018.01.042
_version_ 1783323939214196736
author van Zeeburg, Elsbeth J.T.
Maaijwee, Kristel J.M.
van Meurs, Jan C.
author_facet van Zeeburg, Elsbeth J.T.
Maaijwee, Kristel J.M.
van Meurs, Jan C.
author_sort van Zeeburg, Elsbeth J.T.
collection PubMed
description PURPOSE: To present the 13.5-year-survival of an autologous retinal pigment epithelium (RPE) and choroid graft transplantation with good visual acuity results. OBSERVATIONS: A 72-year old patient presented with a 5-weeks-old visual acuity deterioration to excentric finger counting at half a meter. Fundoscopy showed a fibrotic macular scar, a large subretinal hemorrhage, partly recent, combined with intraretinal fluid, blood, and hard exudates. RPE-choroid graft surgery was performed, and visual acuity improved to 20/32, and maintained up until 13.5 years postoperative. Microperimetry performed at the same time revealed a 3.4 dB sensitivity, with fixation on the graft. During the postoperative years glaucoma developed, an uveitis anterior was treated, and to treat a small Coats' like lesion; one bevacizumab injection was administered. CONCLUSIONS AND IMPORTANCE: A best corrected visual acuity of 20/32 could be achieved and maintained up to 13.5 years after an RPE-choroid graft transplantation, despite an unfavorable preoperative presentation and some early and late complications. This case is a proof of principle that an RPE-choroid graft harvested from the midperiphery can support the macular metabolism up to 13.5 after surgery in a patient with severe exudative AMD. It also represents a rationale for pursuing stem cell derived RPE replacement. Anti-vascular endothelial growth factor injections are nowadays the mainstay of therapy for choroidal neovascularization and/or small hemorrhages and offer good results. Nevertheless, selected patients that cannot benefit from this therapy may profit from an autologous RPE-choroid graft transplantation.
format Online
Article
Text
id pubmed-5956743
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59567432018-05-18 Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation van Zeeburg, Elsbeth J.T. Maaijwee, Kristel J.M. van Meurs, Jan C. Am J Ophthalmol Case Rep Brief report PURPOSE: To present the 13.5-year-survival of an autologous retinal pigment epithelium (RPE) and choroid graft transplantation with good visual acuity results. OBSERVATIONS: A 72-year old patient presented with a 5-weeks-old visual acuity deterioration to excentric finger counting at half a meter. Fundoscopy showed a fibrotic macular scar, a large subretinal hemorrhage, partly recent, combined with intraretinal fluid, blood, and hard exudates. RPE-choroid graft surgery was performed, and visual acuity improved to 20/32, and maintained up until 13.5 years postoperative. Microperimetry performed at the same time revealed a 3.4 dB sensitivity, with fixation on the graft. During the postoperative years glaucoma developed, an uveitis anterior was treated, and to treat a small Coats' like lesion; one bevacizumab injection was administered. CONCLUSIONS AND IMPORTANCE: A best corrected visual acuity of 20/32 could be achieved and maintained up to 13.5 years after an RPE-choroid graft transplantation, despite an unfavorable preoperative presentation and some early and late complications. This case is a proof of principle that an RPE-choroid graft harvested from the midperiphery can support the macular metabolism up to 13.5 after surgery in a patient with severe exudative AMD. It also represents a rationale for pursuing stem cell derived RPE replacement. Anti-vascular endothelial growth factor injections are nowadays the mainstay of therapy for choroidal neovascularization and/or small hemorrhages and offer good results. Nevertheless, selected patients that cannot benefit from this therapy may profit from an autologous RPE-choroid graft transplantation. Elsevier 2018-02-01 /pmc/articles/PMC5956743/ /pubmed/29780916 http://dx.doi.org/10.1016/j.ajoc.2018.01.042 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Brief report
van Zeeburg, Elsbeth J.T.
Maaijwee, Kristel J.M.
van Meurs, Jan C.
Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation
title Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation
title_full Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation
title_fullStr Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation
title_full_unstemmed Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation
title_short Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation
title_sort visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation
topic Brief report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956743/
https://www.ncbi.nlm.nih.gov/pubmed/29780916
http://dx.doi.org/10.1016/j.ajoc.2018.01.042
work_keys_str_mv AT vanzeeburgelsbethjt visualacuityof2032135yearsafteraretinalpigmentepitheliumandchoroidgrafttransplantation
AT maaijweekristeljm visualacuityof2032135yearsafteraretinalpigmentepitheliumandchoroidgrafttransplantation
AT vanmeursjanc visualacuityof2032135yearsafteraretinalpigmentepitheliumandchoroidgrafttransplantation